Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Plasma proteomics in septic shock and alcohol-related pancreatitis: a hyaluronan-centered approach
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Anaesthesiology and Intensive Care.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Anaesthesiology and Intensive Care.
Division of Anaesthesia and Intensive Care Medicine, Intensive Care Units, Department of Surgery, Helsinki University Hospital, 260, Helsinki, Finland.
Proteomics Core Facility, Sahlgrenska Academy, University of Gothenburg, 41390, Gothenburg, Sweden.
Show others and affiliations
2025 (English)In: Clinical Proteomics, ISSN 1542-6416, E-ISSN 1559-0275, Vol. 22, no 1, article id 31Article in journal (Refereed) Published
Abstract [en]

Background: Sepsis is a critical condition characterized by a dysregulated immune response to infection. As sepsis develops to septic shock, its most severe form, morbidity and mortality increases. Hyaluronan is a key component of the extracellular matrix and the endothelial glycocalyx. In sepsis, plasma hyaluronan concentrations are increased and correlate with disease severity. In this study we aimed to explore and compare the proteomic profiles of hyaluronan-associated proteins in patients with the dysregulated immune response of septic shock and the sterile inflammation of acute alcohol-related pancreatitis.

Methods: The present study involved proteomic analysis of patients with septic shock (n = 13), pancreatitis (n = 8), and healthy controls (n = 8). LC-MS/MS was conducted for peptide analysis. Hyaluronan-associated proteins were identified using the UniProt REST API, followed by functional and pathway enrichment analyses with GOATOOLS and GSEApy. Statistical analyses, including ANOVA and post hoc tests, were performed using Python and SPSS, with significance set at p < 0.05.

Results: From a total sum of 663 detected unique plasma proteins, 15 were identified as hyaluronan-related proteins. Plasma levels of 11/15 proteins separated septic shock from pancreatitis in a statistically significant manner. Between the groups differences were apparent on day 1 (8 proteins in septic shock versus 3 in pancreatitis) and day 4 (6 proteins in septic shock versus 3 in pancreatitis) relative to controls. Functional enrichment analysis revealed associations with extracellular matrix organization, proteolytic enzyme regulation, and hyaluronan metabolism. Notably, members of the inter-alpha-inhibitor family demonstrated distinct patterns, with ITIH3 levels increasing and ITIH1, ITIH2, and ITIH4 levels decreasing in septic shock compared to controls. Additionally, plasma hyaluronidase inhibition correlated positively with ITIH3 levels.

Conclusion: The present study explored the role of hyaluronan-related proteins in septic shock pathophysiology, revealing potential dysregulation associated with sepsis severity. The decrease in ITIH1, ITIH2 and ITIH4, as compared to the increase in ITIH3, suggest a complex alteration in the protein balance of the I alpha I-family in sepsis. Overall, the altered proteomic profile of hyaluronan-related proteins as reflected by the GO terms indicates a complex dysregulation not only in hyaluronan metabolism and extracellular matrix, but also in the regulation of several proteolytic enzymes. Future studies on this area are warranted.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2025. Vol. 22, no 1, article id 31
Keywords [en]
Proteomics, Sepsis, Pancreatitis, Hyaluronan, Hyaluronidase, Hyaluronidase inhibition, Inter-alpha-trypsin inhibitor, Extracellular matrix, Glycocalyx
National Category
Anesthesiology and Intensive Care Cell and Molecular Biology Hematology
Identifiers
URN: urn:nbn:se:uu:diva-567353DOI: 10.1186/s12014-025-09556-2ISI: 001561169800001PubMedID: 40885913Scopus ID: 2-s2.0-105014884649OAI: oai:DiVA.org:uu-567353DiVA, id: diva2:1999685
Available from: 2025-09-22 Created: 2025-09-22 Last updated: 2026-06-22Bibliographically approved
In thesis
1. Dynamics of Hyaluronan and Related Proteins in Septic Shock
Open this publication in new window or tab >>Dynamics of Hyaluronan and Related Proteins in Septic Shock
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Septic shock results from a dysregulated host response to infection, leading to life-threatening organ dysfunction. Limited treatment options and a heterogeneous, complex pathophysiology make septic shock a major challenge for clinicians and researchers. Hyaluronan is a versatile molecule that may influence several biological processes disrupted in septic shock, including macro- and microcirculation, endothelial and glycocalyx integrity, intravascular volume, and inflammation. This thesis aimed to deepen understanding of hyaluronan and its associated proteins in septic shock and to explore potential new treatments.

Study I analysed plasma hyaluronan, hyaluronidase activity, and endogenous hyaluronidase inhibition in experimental and clinical septic shock and in acute alcohol-related pancreatitis. Both the experimental control group and septic shock groups showed increased plasma hyaluronan and hyaluronidase inhibition with decreased hyaluronidase activity. This pattern was also observed in clinical septic shock, but in alcohol-related pancreatitis only plasma hyaluronidase activity was reduced.

Study II evaluated high-molecular-weight hyaluronan as an adjuvant to fluid resuscitation at the onset of septic shock in an experimental peritonitis model. A hyaluronan injection followed by infusion throughout the experiment did not reduce resuscitation requirements or alter the inflammatory response.

Study III investigated higher exposure to high-molecular-weight hyaluronan during the early phase of peritonitis-induced septic shock. Hyaluronan infusion, started immediately after induction of peritonitis, did not prevent vascular depletion after 6 hours, nor did it preserve glycocalyx integrity.

Study IV compared proteomic profiles of hyaluronan-related proteins between septic shock and acute alcohol-related pancreatitis. 663 proteins were identified of which 231 were up- or downregulated in septic shock and fifteen were identified as hyaluronan-related. Changes were more pronounced on day 1 than on day 4, and more marked in septic shock than in pancreatitis. Heavy chains of the inter-alpha-inhibitor family showed marked changes: ITIH1, ITIH2, and ITIH4 were decreased, whereas ITIH3 was increased.

In summary, plasma hyaluronan and endogenous hyaluronidase inhibition increased whereas hyaluronidase activity decreased in experimental and clinical septic shock. Supraphysiological hyaluronan concentrations did not prevent intravascular volume depletion, nor did they alter the inflammatory response or preserve glycocalyx integrity. Proteomic profiles of hyaluronan-related proteins differed markedly between septic shock and alcohol-induced pancreatitis. 

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 78
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2280
Keywords
Intensive care, Critical Care, Sepsis, Septic shock, Hyaluronan, Hyaluronidase, Hyaluronidase inhibitor, Inter-alpha-inhibitor, Pre-alpha-trypsin inhibitor, Glycocalyx, Drag-reducing polymers
National Category
Anesthesiology and Intensive Care
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-581137 (URN)978-91-513-2872-0 (ISBN)
Public defence
2026-08-28, H:son Holmdahlsalen, Uppsala University Hospital, entrance 100, Uppsala, 13:00 (English)
Opponent
Supervisors
Available from: 2026-06-04 Created: 2026-05-05 Last updated: 2026-06-04

Open Access in DiVA

fulltext(1656 kB)210 downloads
File information
File name FULLTEXT01.pdfFile size 1656 kBChecksum SHA-512
7ccc9c6e3a57d4940c6077758fb70dd0fb4906db081e3a5e2681f6287626ecc586c1e7ab2a083145c7dba9b2429d262cb5b7824820c70511846108fd80494bfa
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

van der Heijden, JaapTenhunen, JyrkiBarrueta Tenhunen, Annelie

Search in DiVA

By author/editor
van der Heijden, JaapTenhunen, JyrkiBarrueta Tenhunen, Annelie
By organisation
Anaesthesiology and Intensive Care
In the same journal
Clinical Proteomics
Anesthesiology and Intensive CareCell and Molecular BiologyHematology

Search outside of DiVA

GoogleGoogle Scholar
Total: 211 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 337 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf